Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · page 37 of 37
Includes a footnote regarding a 1-for-25 reverse stock split effective September 8, 2023.
Pitch deck · appendix_data · analyze_data · dense density
Slide locked Sign in to view
Slide schematic 4/4
disclaimer 1/1 list 1/1 table 1/1 title 1/1
Components 4
disclaimer bullet data headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.